| scholarly article | Q13442814 |
| P50 | author | Gen Li | Q57614143 |
| P2093 | author name string | Hongya Wu | |
| Fang Xie | |||
| Xueguang Zhang | |||
| Qiu Chen | |||
| Anqing Wu | |||
| Dandan Qi | |||
| Fengmei Cui | |||
| Yanan Zeng | |||
| Yongping Gu | |||
| P2860 | cites work | Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains | Q24310724 |
| Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA | Q24568308 | ||
| Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth | Q24620395 | ||
| Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist | Q24623979 | ||
| IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts | Q28267624 | ||
| Flagellin promotes the proliferation of gastric cancer cells via the Toll-like receptor 5 | Q28308146 | ||
| Role for Akt3/protein kinase Bgamma in attainment of normal brain size | Q28509294 | ||
| Akt-2 binds to Glut4-containing vesicles and phosphorylates their component proteins in response to insulin | Q28568090 | ||
| Insulin increases the association of Akt-2 with Glut4-containing vesicles | Q28573673 | ||
| Protein kinase B alpha/Akt1 regulates placental development and fetal growth | Q28588076 | ||
| Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor | Q33633115 | ||
| TLR2-dependent induction of IL-10 and Foxp3+ CD25+ CD4+ regulatory T cells prevents effective anti-tumor immunity induced by Pam2 lipopeptides in vivo | Q33886184 | ||
| TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome | Q34125049 | ||
| Cytokine signaling in 2002: new surprises in the Jak/Stat pathway | Q34126053 | ||
| TLR9 is critical for glioma stem cell maintenance and targeting | Q34204722 | ||
| The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy | Q34373036 | ||
| An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models | Q34769152 | ||
| Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion. | Q34787194 | ||
| A novel systemically administered Toll-like receptor 7 agonist potentiates the effect of ionizing radiation in murine solid tumor models | Q34853959 | ||
| The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells | Q35176439 | ||
| Radioprotector WR-2721 and mitigating peptidoglycan synergistically promote mouse survival through the amelioration of intestinal and bone marrow damage | Q35234026 | ||
| Gastrointestinal complications of pelvic radiotherapy: are they of any importance? | Q35598210 | ||
| Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. | Q35965439 | ||
| TLR2 and TLR4 stimulation differentially induce cytokine secretion in human neonatal, adult, and murine mononuclear cells | Q36106287 | ||
| Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition | Q36320600 | ||
| Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response | Q36370595 | ||
| A novel AKT3 mutation in melanoma tumours and cell lines | Q36944047 | ||
| Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future | Q36955139 | ||
| Immune-mediated signaling in intestinal goblet cells via PI3-kinase- and AKT-dependent pathways | Q36977078 | ||
| Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients | Q36988575 | ||
| Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer | Q37051019 | ||
| Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. | Q37068617 | ||
| TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy | Q37567832 | ||
| CpG oligodeoxynucleotides as TLR9 agonists: therapeutic applications in cancer. | Q37628645 | ||
| Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity | Q37638328 | ||
| Blockade of TLR3 protects mice from lethal radiation-induced gastrointestinal syndrome | Q37646726 | ||
| Toll-like receptors: cost or benefit for cancer? | Q37661585 | ||
| Interleukin-13 and its receptors in colorectal cancer (Review). | Q38197617 | ||
| Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction | Q38317997 | ||
| Keratinocytes treated with peptidoglycan from Staphylococcus aureus produce vascular endothelial growth factor, and its expression is amplified by the subsequent production of interleukin-13. | Q39816072 | ||
| Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. | Q40866700 | ||
| Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism | Q40950606 | ||
| TLR2 limits development of hepatocellular carcinoma by reducing IL18-mediated immunosuppression | Q41534407 | ||
| The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer | Q41785872 | ||
| Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. | Q41983843 | ||
| Advances in radiotherapy and targeted therapies for rectal cancer | Q42750637 | ||
| IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. | Q42818303 | ||
| Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. | Q44605205 | ||
| Lentiviral-mediated interleukin-4 and interleukin-13 RNA interference decrease airway inflammation and hyperresponsiveness | Q44911304 | ||
| Flagellin and LPS each restores rat lymphocyte populations after colorectal irradiation | Q45400470 | ||
| Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice | Q45408476 | ||
| Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma. | Q50932085 | ||
| A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition. | Q51092771 | ||
| Non-immunologically-mediated cytotoxicity of Lactobacillus casei and its derivative peptidoglycan against tumor cell lines | Q72710257 | ||
| The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway | Q73784963 | ||
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| P304 | page(s) | 75685-75697 | |
| P577 | publication date | 2016-09-30 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Differential effects of peptidoglycan on colorectal tumors and intestinal tissue post-pelvic radiotherapy | |
| P478 | volume | 7 |
| Q92481915 | TLR2 deficiency enhances susceptibility to oral carcinogenesis by promoting an inflammatory environment | cites work | P2860 |
Search more.